Common thymulin questions
Thymulin FAQ: the questions readers ask, answered from the record.
Short, cited answers to the most common thymulin questions - identity, zinc dependence, gene therapy, and the human-data gaps.
What is thymulin?
Thymulin is a zinc-dependent thymic nonapeptide hormone produced exclusively by thymic epithelial cells; it is biologically active only when bound to zinc in a 1:1 ratio [1][2]. It is studied as a research peptide across immune, anti-inflammatory, and neuroendocrine models, and it is not FDA-approved for any use.
What is thymulin peptide?
Thymulin is a linear nonapeptide with the sequence pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn that becomes biologically active only after binding one zinc ion per molecule [1][2]. Its molecular formula is C33H54N12O15 and its molecular weight is about 858.86 Da. The zinc-free apopeptide is inactive.
Is thymulin the same as serum thymic factor (FTS)?
Yes in lineage. Serum thymic factor (FTS) is the original name for the same peptide; FTS denotes the zinc-free peptide, and once zinc binds in a 1:1 ratio the active form was named thymulin (FTS-Zn) [1]. They are two states of one molecule: the inactive apo form and the active zinc-loaded form.
What is the amino acid sequence of thymulin?
Thymulin is the nonapeptide pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn (written <Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn), with molecular formula C33H54N12O15 [2]. The pyroGlu at the start is a cyclized glutamate residue. This exact sequence is what distinguishes thymulin from other thymic peptides.
Why does thymulin need zinc to work?
Binding one zinc ion per peptide drives a specific active conformation; the zinc-free apopeptide is inactive [2]. In the original work, chelating zinc abolished activity and adding zinc back restored it at a 1:1 metal-to-peptide ratio [1]. Zinc organizes the active shape - it is the switch, not an optional extra.
What does thymulin do in the body?
Endogenously, thymulin contributes to T-lymphocyte differentiation and immune-cell modulation and acts as a hypophysiotropic peptide in a bidirectional thymus-neuroendocrine axis [4]. Circulating levels peak in childhood and decline with age and zinc deficiency [4][14]. Its level tracks both thymic function and the body's zinc status.
What are the benefits of thymulin peptide?
In research models, thymulin has shown anti-inflammatory, immune-modulating, anti-hyperalgesic, and - via gene therapy - lung-protective effects [6][7]. All are study findings in named species or in-vitro systems, not demonstrated human benefits. There is no clinical benefit established for people.
What are the benefits of thymulin?
Documented research effects include suppression of pro-inflammatory cytokines and NF-kB signaling, reduced inflammatory hyperalgesia, and immunomodulation in autoimmune and metabolic models, all in animals or cells [6][9]. The endogenous role adds T-cell differentiation [4]. These are model findings, never a human treatment claim.
Does thymulin boost the immune system?
Thymulin's classical role is driving T-cell differentiation and modulating immune-cell function [4]; in zinc-deficiency and aging models, restoring zinc-bound thymulin was associated with improved immune measures [3][14]. This is research-model evidence, not a clinical immune-boosting claim, and the effects are entangled with zinc status.
Does thymulin reduce inflammation?
In LPS, septic, autoimmune, and diabetic mouse models, thymulin was associated with lower pro-inflammatory cytokines and reduced NF-kB and SAPK/JNK signaling [6]. These are animal and in-vitro findings describing what thymulin did in those models, not an anti-inflammatory treatment effect demonstrated in humans.
Can thymulin help with autoimmune disease?
In rodent experimental autoimmune encephalomyelitis (a multiple-sclerosis model), thymulin reduced disease severity and, with peroxiredoxin 6, supported blood-brain-barrier integrity [9][11]. These are preclinical results in mice, not evidence of treatment in people, and no autoimmune indication is established.
Does thymulin have anti-aging effects?
Circulating thymulin declines with age and zinc deficiency; in aged mice, zinc repletion was linked to restored thymulin secretion and thymic function [14]. This frames thymulin within zinc-dependent immunosenescence research, not as an anti-aging therapy for humans. Gene therapy to restore it is experimental [5].
Is thymulin studied for pain relief?
In rodent inflammatory and endotoxin models, thymulin and its analog PAT produced dose-dependent reductions in hyperalgesia with a biphasic profile; thymulin alone did not change baseline pain [4]. These are animal findings only, with no established human pain indication.
What is thymulin gene therapy?
An experimental strategy that uses adenoviral or nanoparticle vectors carrying a thymulin-encoding gene to restore sustained circulating thymulin in animal models, developed because the native peptide has a short circulating half-life [5][7]. It is preclinical - studied in mice and rats, not offered to people.
Has thymulin been studied for asthma?
In a mouse model of established allergic asthma, a single inhaled dose of thymulin-expressing plasmid in mucus-penetrating nanoparticles normalized key lung pathologies at 20 days [7]; a separate DNA-nanoparticle study reported prevention of airway remodeling [12]. These are animal findings, not human treatment.
How is thymulin different from thymosin alpha-1?
They are distinct thymic peptides. Thymulin is a zinc-dependent nonapeptide; thymosin alpha-1 is a separate, larger peptide with its own research literature [1][2]. Thymulin's findings should never be attributed to thymosin alpha-1, to thymosin beta-4 (TB-500), or to thymalin (a bovine thymic complex).
How is thymulin administered in research?
In animal and in-vitro studies thymulin has been given by intraperitoneal, subcutaneous, and intracerebroventricular routes, with intratracheal and intramuscular delivery used for gene-therapy vectors and a topical zinc-thymulin pilot in humans [5][7]. There is no approved human route of administration.
What is the dosage of thymulin peptide?
There is no established human dose. Studies report research doses in animals - for example nanogram-to-low-microgram amounts intraperitoneally or intracerebroventricularly - and these are study parameters, not protocols for people [4]. Gene-therapy work used a single vector dose rather than a peptide dose [5].
Is thymulin taken as an injection?
In research, thymulin has been delivered by injection routes (intraperitoneal, subcutaneous, intracerebroventricular) in animals; a human topical zinc-thymulin pilot used a skin formulation [7]. There is no approved human injectable product, and the literature describes experimental routes only.
What doses of thymulin were used in animal studies?
Reported research doses include 0.1-1 microg intracerebroventricularly and 1-1000 ng intraperitoneally in rodent pain models, and roughly 100 ng/kg/day subcutaneously in a rat pulmonary-hypertension study; a mouse study used 50 microg per animal of serum thymic factor [4][15]. Gene-therapy work used a single vector dose rather than a peptide dose [5].
Is there a thymulin supplement?
Thymulin is a research peptide, not an FDA-approved drug and not a dietary supplement [5]. Consumer sources sometimes confuse it with thymosin alpha-1 or with thymalin (a bovine thymic complex); those are different compounds. No legitimate thymulin dietary supplement is established.
It is worth being clear about what the lawful route looks like for the peptides that have one, because thymulin does not: in the United States those compounds are prescription-only, and access runs through licensed telehealth prescribers such as Promise Peptides (mypromise.com), where a clinician evaluates the patient, sets the protocol, and the compound is dispensed against that prescription rather than bought off a shelf. Thymulin has no such pathway - no approved product, no established human dose, no clinical protocol to prescribe - which is why it remains a laboratory subject and why anything sold to consumers under its name should be treated with suspicion.
What is the half-life of thymulin?
As a small peptide, native thymulin has a short circulating half-life, but a precise human pharmacokinetic half-life is not well established in the public literature [5] - one reason gene-therapy approaches were developed to sustain circulating levels. The honest answer is that the human half-life is uncharacterized.